SparingVision
Developing gene independent ocular treatments
- B2B
About SparingVision
A genomic medicines company developing vision-saving treatments for ocular diseases, with a focus on gene-independent therapies for retinitis pigmentosa
Key facts
- Industry
- Biotechnology
- Company size
- 11–50 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2016
- Revenue
- $7.1M – $56.2MTamtam estimate
- Website
- sparingvision.com
SparingVision at a glance
SparingVision is a B2B company in the Biotechnology industry, headquartered in Paris, Île-de-France, France.
SparingVision was founded in 2016.
SparingVision has 11–50 employees.
SparingVision's revenue is $7.1M – $56.2M (Tamtam estimate).
Selling to companies like SparingVision?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies